FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Urbanski Raymond W.
2. Date of Event Requiring Statement (Month/Day/Year)
05/28-06:00/2019
3. Issuer Name and Ticker or Trading Symbol
Applied BioSciences Corp. [APPB]
(Last)
(First)
(Middle)
C/O STONY HILL CORP., 9701 WILSHIRE BLVD, SUITE 1000
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

BEVERLY HILLS, CA 90212
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 25,000
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (1)   (2)   (3) Common Stock 1,000,000 $ 1.23 D  
Stock Option (right to buy) (1)   (4)   (5) Common Stock (6) $ 1.23 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Urbanski Raymond W.
C/O STONY HILL CORP., 9701 WILSHIRE BLVD
SUITE 1000
BEVERLY HILLS, CA 90212
  X     Chief Executive Officer  

Signatures

/s/ Raymond Urbanski 06/04-06:00/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Exempt transaction under SEC Rule 16b-3.
(2) One-third of the option vests on each of the following dates: (i) May 31, 2019, (ii) April 1, 2020, and (iii) April 1, 2021.
(3) Shares vest subject to continued employment with Applied BioSciences Corp. (the "Company"), or an affiliate thereof.
(4) One-third (1/3) of the option vests upon the occurrence of each of the following events: (i) the Company has raised a combined $3,000,000, (ii) opening of the first IND with the FDA, or equivalent ex-US, and (iii) the Company being listed on a national securities exchange.
(5) Shares vest subject to continued employment with the Company, or an affiliate thereof.
(6) That number of shares of common stock equal to 3% of the Company's fully diluted common stock.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.